Cite
Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU
MLA
Jarno, Hoekman, et al. “Characteristics and Follow-up of Postmarketing Studies of Conditionally Authorized Medicines in the EU.” British Journal of Clinical Pharmacology, vol. 82, no. 1, Sept. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........3196104a4387ae67c85f76104c7723db&authtype=sso&custid=ns315887.
APA
Jarno, H., Thea T, K., Aukje K, M.-T., Hubert G M, L., & Marie L, D. B. (2015). Characteristics and follow-up of postmarketing studies of conditionally authorized medicines in the EU. British Journal of Clinical Pharmacology, 82(1).
Chicago
Jarno, Hoekman, Klamer Thea T, Mantel-Teeuwisse Aukje K, Leufkens Hubert G M, and De Bruin Marie L. 2015. “Characteristics and Follow-up of Postmarketing Studies of Conditionally Authorized Medicines in the EU.” British Journal of Clinical Pharmacology 82 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........3196104a4387ae67c85f76104c7723db&authtype=sso&custid=ns315887.